Conditional Control of Alternative Splicing through Light-Triggered Splice-Switching Oligonucleotides

被引:37
|
作者
Hemphill, James [1 ,2 ]
Liu, Qingyang [2 ]
Uprety, Rajendra [2 ]
Samanta, Subhas [1 ]
Tsang, Michael [3 ]
Juliano, Rudolph L. [4 ]
Deiters, Alexander [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
[2] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA
[3] Univ Pittsburgh, Dept Dev Biol, Sch Med, Pittsburgh, PA 15260 USA
[4] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
ANTISENSE OLIGONUCLEOTIDES; INTRACELLULAR DELIVERY; DYSTROPHIN RESTORATION; MUSCULAR-DYSTROPHY; ZEBRAFISH EMBRYOS; NERVOUS-SYSTEM; EXPRESSION; RNA; GENE; SOX31;
D O I
10.1021/jacs.5b00580
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The spliceosome machinery is composed of several proteins and multiple small RNA molecules that are involved in gene regulation through the removal of introns from pre-mRNAs in order to assemble exon-based mRNA containing protein-coding sequences. Splice-switching oligonucleotides (SSOs) are genetic control elements that can be used to specifically control the expression of genes through correction of aberrant splicing pathways. A current limitation with SSO methodologies is the inability to achieve conditional control of their function paired with high spatial and temporal resolution. We addressed this limitation through site-specific installation of light-removable nucleobase-caging groups as well as photocleavable backbone linkers into synthetic SSOs. This enables optochemical OFF -> ON and ON -> OFF switching of their activity and thus precise control of alternative splicing. The use of light as a regulatory element allows for tight spatial and temporal control of splice switching in mammalian cells and animals.
引用
收藏
页码:3656 / 3662
页数:7
相关论文
共 50 条
  • [21] APO-skip splice-switching oligonucleotides to treat familial hypercholesterolemia
    Disterer, Petra
    Simons, J. Paul
    Owen, James S.
    Khoo, Bernard
    HUMAN GENE THERAPY, 2013, 24 (05) : A31 - A31
  • [22] Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
    Kristin A. Ham
    Niall P. Keegan
    Craig S. McIntosh
    May T. Aung-Htut
    Khine Zaw
    Kane Greer
    Sue Fletcher
    Steve D. Wilton
    Scientific Reports, 11
  • [23] Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells
    Kotula, Jonathan W.
    Pratico, Elizabeth D.
    Ming, Xin
    Nakagawa, Osamu
    Juliano, Rudolph L.
    Sullenger, Bruce A.
    NUCLEIC ACID THERAPEUTICS, 2012, 22 (03) : 187 - 195
  • [24] Targeting theERGoncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer
    Li, Ling
    Hobson, Lisa
    Perry, Laura
    Clark, Bethany
    Heavey, Susan
    Haider, Aiman
    Sridhar, Ashwin
    Shaw, Greg
    Kelly, John
    Freeman, Alex
    Wilson, Ian
    Whitaker, Hayley
    Nurmemmedov, Elmar
    Oltean, Sebastian
    Porazinski, Sean
    Ladomery, Michael
    BRITISH JOURNAL OF CANCER, 2020, 123 (06) : 1024 - 1032
  • [25] Splice-Switching Antisense Oligonucleotides for the Treatment of CLN3 Batten Disease
    Centa, Jessica L.
    Jodelka, Francine M.
    Hinrich, Anthony J.
    Johnson, Tyler B.
    Rigo, Frank
    Weimer, Jill M.
    Hastings, Michelle L.
    MOLECULAR THERAPY, 2019, 27 (04) : 303 - 303
  • [26] Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides
    Jarver, Peter
    Zaghloul, Eman M.
    Arzumanov, Andrey A.
    Saleh, Amer F.
    McClorey, Graham
    Hammond, Suzan M.
    Hallbrink, Mattias
    Langel, Ulo
    Smith, C. I. Edvard
    Wood, Matthew J. A.
    Gait, Michael J.
    EL Andaloussi, Samir
    NUCLEIC ACID THERAPEUTICS, 2015, 25 (02) : 65 - 77
  • [27] Correction of IKBKAP exon 20 splicing by splice switching oligonucleotides
    Bruun, G. H.
    Doktor, T. K.
    Andersen, J. S.
    Gronning, A. G. B.
    Andresen, B. S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 627 - 627
  • [28] Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer
    Ling Li
    Lisa Hobson
    Laura Perry
    Bethany Clark
    Susan Heavey
    Aiman Haider
    Ashwin Sridhar
    Greg Shaw
    John Kelly
    Alex Freeman
    Ian Wilson
    Hayley Whitaker
    Elmar Nurmemmedov
    Sebastian Oltean
    Sean Porazinski
    Michael Ladomery
    British Journal of Cancer, 2020, 123 : 1024 - 1032
  • [29] Splice-switching oligonucleotides as therapeutics for citrin deficiency patients with a novel deep intronic variant
    Oishi, Kimihiko
    Ow, Jin Rong
    Imagawa, Eri
    Cher, Wei Yuan
    Ramadass, Venkataramanan
    Tabaglio, Tommaso
    Lakshmanan, Manikandan
    Guccione, Ernesto
    Wee, Keng Boon
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (04)
  • [30] LIGHT-TRIGGERED ELECTRICAL AND OPTICAL SWITCHING DEVICES
    GILAT, SL
    KAWAI, SH
    LEHN, JM
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1993, (18) : 1439 - 1442